BILLERICA, Mass., Dec. 18, 2018 /PRNewswire/ -- Belmont Instrument, LLC, a leading provider of fluid resuscitation and patient temperature management solutions, announced a major rebranding program to reflect the company's evolution into an expanded provider of innovative medical solutions. The comprehensive branding effort elevates the focus on delivering the highest class of product and customer support and includes an updated name (Belmont Medical Technologies), logo, and visual identity.
Belmont Medical Technologies characterizes the new brand as modern and energetic. Belmont's emphasis on providing innovative medical solutions worldwide is reflected in the company's new mission statement, "We work on the front lines of critical care, helping clinicians save lives and improve outcomes. We deliver breakthrough medical solutions that blend technical inspiration with an uncompromising quality standard, earning the trust of patients and clinicians worldwide."
Brian Ellacott, Chief Executive Officer, Belmont, stated "This is an exciting time at Belmont! Through this initiative, we wanted our brand to become a better reflection of our purpose and to more closely align the company with its strategic growth goals. The new name and visual identity reflect our commitment to honor Belmont's strong technical heritage while setting the foundation for strategic growth into new medical technologies."
The new name will be reflected in all future company communications and materials. This transition will occur over the next few months.
About Belmont Medical Technologies
Belmont Medical Technologies is a leading provider of fluid resuscitation and patient temperature management solutions for use worldwide in medical facilities, military combat fields, and EMS settings.
Belmont's premier product is The Belmont® Rapid Infuser RI-2, which utilizes electromagnetic induction heating to provide precise control of fluid temperature and flow rate during fluid resuscitation. Belmont's technology is credited with saving thousands of lives globally by infusing warm blood and fluid into patients experiencing massive blood loss, while exceptional air removal features help keep the patient safe from air embolism. Belmont also offers the close-to-patient, IV pole mounted buddy 2™ and portable, battery-operated buddy lite™ for all low-flow hospital and pre-hospital blood and fluid warming.
Belmont's most recent technology acquisition extends its portfolio to include non-invasive body temperature management solutions. Belmont's advanced targeted temperature solutions include the Allon® system with ThermoWrap® patient garment, and the CritiCool® system with CureWrap™ patient garment. These non-invasive solutions are designed to enable healthcare providers to exercise precise control and management of patient body temperature.
Belmont is a portfolio company of Audax Private Equity ("Audax"). Since its founding in 1999, Audax Private Equity has been focused on building leading middle market companies. Audax has invested $5 billion in 119 platform and 718 add-on companies. Through its disciplined Buy & Build approach, Audax seeks to help platform companies execute add-on acquisitions that fuel revenue growth, optimize operations, and significantly increase equity value.